Skip to main content
. 2017 Jun 22;7:83–90. doi: 10.1016/j.ajoc.2017.06.011

Table 1.

Clinical summary of cases with membranoproliferative glomerulonephritis with positive eye exam.

Case 1 Case 2 Case 3 Case 4
Age at first presentation 52 14 24 52
Gender Female Female Male Female
Race Caucasian Caucasian Caucasian Caucasian
Systemic disease Diabetes mellitus; HTN Diabetes mellitus; HTN HTN Monoclonal gammopathy
Type of MPGN II* Probably Primary** II* Probably Secondary*
Duplication of basal lamina of glomerulus Yes Yes Yes Yes
Antibodies present (IgG, IgM) No Yes Yes Yes
Complement present (C3) Yes Yes Yes Yes
Smoker No No No No
Age at dx of MPGN 50 28 24 55
HTN duration (years) 2 26 3 No HTN
Hemoglobin level serum 11.0 13.0 11.1 NA
Serum creatinine mg/dl 2.2 1.6 1.5 5.0
Oral corticosteroid intake Yes Yes No Yes
Mycophenolate mofetil intake Yes Yes No Yes
Age at first diagnosis of drusen 50 29 24 55
Initial vision 20/25 OD 20/20 OS 20/20 OD 20/30 OS 20/20 OD 20/20 OS 20/60 OD 20/40 OS
Final vision 20/25 OD 20/20 OS 20/30 OD 20/30 OS 20/20 OD 20/20 OS 20/200 OD 20/40 OS
Length of follow-up (years) 1.5 37 2.5 2.0
Drusen type (laminar) Yes Yes Yes Yes
Drusen location Diffuse till equator Diffuse till equator Macula Posterior pole
Drusen size (microns) 50 200 25 50
Fundus Autofluorescence Yes Yes No Yes
Diffuse thickening of Bruch's membrane Yes Yes No Yes
Serous retinal detachment No Yes No Yes
RPE detachment No Yes No Yes
Choroidal new vessel No No No No

Abbreviations: HTN, systemic hypertension; MPGN, membranoproliferative glomerulonephritis; NA, not assessed; OD, right eye; OS, left eye, RPE, retinal pigment epithelium (one asterisk refers to documentation by transmission electron microscopy, and 2 asterisks refers to negative workup for secondary causes of MPGN).